4//SEC Filing
PYXIS INNOVATIONS INC 4
Accession 0000950138-13-000227
CIK 0001037649other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 12:57 PM ET
Size
15.9 KB
Accession
0000950138-13-000227
Insider Transaction Report
Form 4
ALTICOR INC
10% Owner
Transactions
- Conversion
Convertible Promissory Notes
2013-05-17−14,316,255→ 0 totalExercise: $5.68→ Common Stock (2,521,222 underlying) - Conversion
Common Stock
2013-05-17+28,160,200→ 35,044,256 total - Conversion
Common Stock
2013-05-17$5.68/sh+2,521,222$14,316,255→ 37,565,478 total - Conversion
Series A-1 Preferred Stock
2013-05-17−5,000,000→ 0 total→ Common Stock (28,160,200 underlying)
Alticor Global Holdings Inc.
10% Owner
Transactions
- Conversion
Common Stock
2013-05-17+28,160,200→ 35,044,256 total - Conversion
Series A-1 Preferred Stock
2013-05-17−5,000,000→ 0 total→ Common Stock (28,160,200 underlying) - Conversion
Convertible Promissory Notes
2013-05-17−14,316,255→ 0 totalExercise: $5.68→ Common Stock (2,521,222 underlying) - Conversion
Common Stock
2013-05-17$5.68/sh+2,521,222$14,316,255→ 37,565,478 total
SOLSTICE HOLDINGS INC
10% Owner
Transactions
- Conversion
Convertible Promissory Notes
2013-05-17−14,316,255→ 0 totalExercise: $5.68→ Common Stock (2,521,222 underlying) - Conversion
Common Stock
2013-05-17$5.68/sh+2,521,222$14,316,255→ 37,565,478 total - Conversion
Common Stock
2013-05-17+28,160,200→ 35,044,256 total - Conversion
Series A-1 Preferred Stock
2013-05-17−5,000,000→ 0 total→ Common Stock (28,160,200 underlying)
PYXIS INNOVATIONS INC
10% Owner
Transactions
- Conversion
Common Stock
2013-05-17$5.68/sh+2,521,222$14,316,255→ 37,565,478 total - Conversion
Common Stock
2013-05-17+28,160,200→ 35,044,256 total - Conversion
Convertible Promissory Notes
2013-05-17−14,316,255→ 0 totalExercise: $5.68→ Common Stock (2,521,222 underlying) - Conversion
Series A-1 Preferred Stock
2013-05-17−5,000,000→ 0 total→ Common Stock (28,160,200 underlying)
Footnotes (2)
- [F1]On May 17, 2013, Pyxis Innovations Inc. ("Pyxis") converted 5,000,000 shares of the Issuer's Series A-1 preferred stock into 28,160,200 shares of common stock. The Series A-1 was convertible into an aggregate of 28,160,200 shares of the Issuer's common stock (equal to $9 million divided by $0.3196, under the terms of the Series A-1 Preferred Stock). Such conversion right did not expire.
- [F2]On May 17, 2013, Pyxis converted seven convertible promissory notes in the aggregate principal amount of $14,316,255 issued by the Issuer at a conversion price of $5.6783 per share, resulting in the acquisition by Pyxis of 2,521,222 shares of the Issuer's common stock. The notes were convertible at any time before the payment in full of notes, which had a maturity date of March 31, 2014.
Documents
Issuer
INTERLEUKIN GENETICS INC
CIK 0001037649
Entity typeother
Related Parties
1- filerCIK 0001221575
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 12:57 PM ET
- Size
- 15.9 KB